Showing results (41-50 of 97) with videos related to
Sort By:
Pageof 10
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2013
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CTAxel Wetter, Christine Lipponer, Felix Nensa, et al.Acta Radiologica (Stockholm, Sweden : 1987)|November 16, 2014
Impact of dual-energy CT prior to radioembolization (RE)Jens-Christian Altenbernd, Ilka von der Stein, Axel Wetter, et al.European Thyroid Journal|July 24, 2024
Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinomaPepijn van Houten, James Nagarajah, Janneke E W Walraven, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 31, 2014
Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET: feasibility of a metabolic grading systemSamer Ezziddin, Linda Adler, Amir Sabet, et al.Theranostics|August 9, 2023
Click-to-Release: Cleavable Radioimmunoimaging with [89Zr]Zr-DFO-Trans-Cyclooctene-Trastuzumab Increases Tumor-to-Blood RatioMaria Vlastara, Raffaella Rossin, Freek J M Hoeben, et al.EJNMMI Reports|November 26, 2024
[18F]PSMA-1007 PET for biochemical recurrence of prostate cancer, a comparison with [18F]FluciclovineCato C Loeff, Willemijn van Gemert, Bastiaan M Privé, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2012
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trialsFrançoise Kraeber-Bodéré, Thomas Carlier, Valérie Meresse Naegelen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 22, 2014
Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imagingWalter Jentzen, Jan Hoppenbrouwers, Paul van Leeuwen, et al.Cancers|May 14, 2022
An Explorative Study of the Incidental High Renal Excretion of [18F]PSMA-1007 for Prostate Cancer PET/CT ImagingYoussra Allach, Amina Banda, Willemijn van Gemert, et al.European Urology Focus|August 5, 2026
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone-sensitive Prostate Cancer (BULLSEYE): A Trial UpdateBastiaan M Privé, Daniela E Oprea-Lager, Constantijn H J Muselaers, et al.Pageof 10